These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17110226)

  • 1. Pemphigus foliaceus treated with etanercept.
    Gubinelli E; Bergamo F; Didona B; Annessi G; Atzori F; Raskovic D
    J Am Acad Dermatol; 2006 Dec; 55(6):1107-8. PubMed ID: 17110226
    [No Abstract]   [Full Text] [Related]  

  • 2. A pilot study of etanercept treatment for pemphigus vulgaris.
    Fiorentino DF; Garcia MS; Rehmus W; Kimball AB
    Arch Dermatol; 2011 Jan; 147(1):117-8. PubMed ID: 21242406
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of pemphigus vulgaris with etanercept in four patients.
    Shetty A; Marcum CB; Glass LF; Carter JD
    J Drugs Dermatol; 2009 Oct; 8(10):940-3. PubMed ID: 19852124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of pemphigus vulgaris in a patient with psoriasis treated with etanercept.
    Daulat S; Detweiler JG; Pandya AG
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):483-4. PubMed ID: 18793242
    [No Abstract]   [Full Text] [Related]  

  • 5. Psoriasis and hepatitis C treated with anti-TNF alpha therapy (etanercept).
    Cecchi R; Bartoli L
    Dermatol Online J; 2006 Dec; 12(7):4. PubMed ID: 17459290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of etanercept in children.
    Wargula JC; Lovell DJ
    Bull Rheum Dis; 2000; 49(12):1-4. PubMed ID: 11314579
    [No Abstract]   [Full Text] [Related]  

  • 7. Treating leukocytoclastic vasculitis associated with etanercept therapy. Is it necessary to stop etanercept?
    Juan A; Ribas B; Nadal C; Ros I
    J Rheumatol; 2005 Oct; 32(10):2061; author reply 2061-2. PubMed ID: 16206372
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphoedema: a rare complication of inflammatory rheumatism. Successful treatment with etanercept.
    Doffoël-Hantz V; Sparsa A; Verbeke S; Tricard MJ; Bonnetblanc JM; Bédane C
    Eur J Dermatol; 2007; 17(4):337-8. PubMed ID: 17540645
    [No Abstract]   [Full Text] [Related]  

  • 9. TNF-alpha inhibition for potential therapeutic modulation of SARS coronavirus infection.
    Tobinick E
    Curr Med Res Opin; 2004 Jan; 20(1):39-40. PubMed ID: 14741070
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of tumor necrosis factor alpha for refractory asthma.
    Erzurum SC
    N Engl J Med; 2006 Feb; 354(7):754-8. PubMed ID: 16481645
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe psoriasis pustulosa palmaris et plantaris (Barber-Königsbeck) treated successfully with soluble tumour necrosis factor receptor fusion protein (etanercept).
    Kasche A; Pfab F; Hein R; Athanasiadis GI; Ollert M; Ring J; Eberlein-König B
    J Eur Acad Dermatol Venereol; 2007 Feb; 21(2):255-7. PubMed ID: 17243968
    [No Abstract]   [Full Text] [Related]  

  • 12. Etanercept in infants: suberythrodermic, recalcitrant psoriasis in a 22 month-old child successfully treated with etanercept.
    Fabrizi G; Guerriero C; Pagliarello C
    Eur J Dermatol; 2007; 17(3):245. PubMed ID: 17478389
    [No Abstract]   [Full Text] [Related]  

  • 13. Etanercept for toxic epidermal necrolysis.
    Famularo G; Di Dona B; Canzona F; Girardelli CR; Cruciani G
    Ann Pharmacother; 2007 Jun; 41(6):1083-4. PubMed ID: 17456541
    [No Abstract]   [Full Text] [Related]  

  • 14. Commentary on the European S3-guidelines on the systemic treatment of psoriasis.
    Giannetti A
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):368; author reply 368-9. PubMed ID: 20070453
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients.
    Canizares MJ; Smith DI; Conners MS; Maverick KJ; Heffernan MP
    Arch Dermatol; 2006 Nov; 142(11):1457-61. PubMed ID: 17116836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retrospective study of etanercept use in elderly people with psoriasis].
    Ruiz-Villaverde R; Sanchez-Cano D; Abalos-Medina GM
    Rev Esp Geriatr Gerontol; 2010; 45(1):56-7. PubMed ID: 19939506
    [No Abstract]   [Full Text] [Related]  

  • 17. Low remission rates but long drug survival in rheumatoid arthritis patients treated with infliximab or etanercept: results from the nationwide Danish DANBIO database.
    Ostergaard M; Unkerskov J; Linde L; Krogh NS; Ravn T; Ringsdal VS; Petri A; Andersen LS; Tarp U; Hansen A; Hjardem E; Hetland ML
    Scand J Rheumatol; 2007; 36(2):151-4. PubMed ID: 17476624
    [No Abstract]   [Full Text] [Related]  

  • 18. Sustained response to etanercept after failing infliximab, in a patient with relapsing polychondritis with tracheomalacia.
    Subrahmanyam P; Balakrishnan C; Dasgupta B
    Scand J Rheumatol; 2008; 37(3):239-40. PubMed ID: 18465465
    [No Abstract]   [Full Text] [Related]  

  • 19. Consecutive use of different biological therapies in the treatment of psoriasis.
    Costanzo A; Papoutsaki M; Mazzotta A; Chimenti S
    Br J Dermatol; 2007 Aug; 157(2):394. PubMed ID: 17553044
    [No Abstract]   [Full Text] [Related]  

  • 20. Pyoderma gangrenosum treated with anti-TNF alpha therapy (etanercept).
    Pastor N; Betlloch I; Pascual JC; Blanes M; Bañuls J; Silvestre JF
    Clin Exp Dermatol; 2006 Jan; 31(1):152-3. PubMed ID: 16309525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.